These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23807614)

  • 1. Variations in predicted risks in personal genome testing for common complex diseases.
    Kalf RR; Mihaescu R; Kundu S; de Knijff P; Green RC; Janssens AC
    Genet Med; 2014 Jan; 16(1):85-91. PubMed ID: 23807614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-to-consumer personal genome testing for age-related macular degeneration.
    Buitendijk GH; Amin N; Hofman A; van Duijn CM; Vingerling JR; Klaver CC
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6167-74. PubMed ID: 25146986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of personal genome services for Japanese individuals.
    Kido T; Kawashima M; Nishino S; Swan M; Kamatani N; Butte AJ
    J Hum Genet; 2013 Nov; 58(11):734-41. PubMed ID: 24067293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer.
    Lello L; Raben TG; Yong SY; Tellier LCAM; Hsu SDH
    Sci Rep; 2019 Oct; 9(1):15286. PubMed ID: 31653892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers.
    Jakobsdottir J; Gorin MB; Conley YP; Ferrell RE; Weeks DE
    PLoS Genet; 2009 Feb; 5(2):e1000337. PubMed ID: 19197355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of direct-to-consumer genetic tests.
    Kaye J
    Hum Mol Genet; 2008 Oct; 17(R2):R180-3. PubMed ID: 18852208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance study of 3 direct-to-consumer genetic-testing services.
    Imai K; Kricka LJ; Fortina P
    Clin Chem; 2011 Mar; 57(3):518-21. PubMed ID: 21159896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-based risk and pharmacogenetic sampling in clinical trials.
    Schork NJ; Topol EJ
    J Biopharm Stat; 2010 Mar; 20(2):315-33. PubMed ID: 20309761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of commercial genetic-testing services in Korea with 23andMe service.
    Kim S; Eom KW; Cho CR; Um TH
    Biomed Res Int; 2014; 2014():539151. PubMed ID: 25057494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of disease characteristics in the ethical debate on personal genome testing.
    Bunnik EM; Schermer MH; Janssens AC
    BMC Med Genomics; 2012 Jan; 5():4. PubMed ID: 22260407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.
    Seddon JM; Reynolds R; Yu Y; Daly MJ; Rosner B
    Ophthalmology; 2011 Nov; 118(11):2203-11. PubMed ID: 21959373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of risk prediction updates from commercial genome-wide scans.
    Mihaescu R; van Hoek M; Sijbrands EJ; Uitterlinden AG; Witteman JC; Hofman A; van Duijn CM; Janssens AC
    Genet Med; 2009 Aug; 11(8):588-94. PubMed ID: 19636253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics. Delivering new disease genes.
    Cardon LR
    Science; 2006 Dec; 314(5804):1403-5. PubMed ID: 17138888
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysis.
    Smith JG; Almgren P; Engström G; Hedblad B; Platonov PG; Newton-Cheh C; Melander O
    J Intern Med; 2012 Dec; 272(6):573-82. PubMed ID: 22690879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record.
    Ritchie MD; Denny JC; Crawford DC; Ramirez AH; Weiner JB; Pulley JM; Basford MA; Brown-Gentry K; Balser JR; Masys DR; Haines JL; Roden DM
    Am J Hum Genet; 2010 Apr; 86(4):560-72. PubMed ID: 20362271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk categorization for complex disorders according to genotype relative risk and precision in parameter estimates.
    Goddard GH; Lewis CM
    Genet Epidemiol; 2010 Sep; 34(6):624-32. PubMed ID: 20568294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.
    de Breuk A; Acar IE; Kersten E; Schijvenaars MMVAP; Colijn JM; Haer-Wigman L; Bakker B; de Jong S; Meester-Smoor MA; Verzijden T; Missotten TOAR; Monés J; Biarnés M; Pauleikhoff D; Hense HW; Silva R; Nunes S; Melo JB; Fauser S; Hoyng CB; Ueffing M; Coenen MJH; Klaver CCW; den Hollander AI;
    Ophthalmology; 2021 Nov; 128(11):1604-1617. PubMed ID: 32717343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.
    Seddon JM; Silver RE; Kwong M; Rosner B
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2192-202. PubMed ID: 25655794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reclassification of genetic-based risk predictions as GWAS data accumulate.
    Krier J; Barfield R; Green RC; Kraft P
    Genome Med; 2016 Feb; 8(1):20. PubMed ID: 26884246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promissory accounts of personalisation in the commercialisation of genomic knowledge.
    Arribas-Ayllon M; Sarangi S; Clarke A
    Commun Med; 2011; 8(1):53-66. PubMed ID: 22616356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.